Modeling The Population Dynamics Of Erythrocytes To Identify Optimal Drug Dosages For The Treatment Of Hepatitis C Virus Infection
The current treatment for hepatitis C virus (HCV) infection – combination therapy with pegylated interferon and ribavirin – elicits sustained responses in only ~50% of the patients treated. Greater cumulative exposure to ribavirin increases response to interferon-ribavirin combination therapy. A key...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | en_US |
| Published: |
2016
|
| Subjects: | |
| Online Access: | http://etd.iisc.ernet.in/handle/2005/2527 http://etd.ncsi.iisc.ernet.in/abstracts/3278/G25569-Abs.pdf |